Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2020
The impact of hypoglycemia on healthcare costs: a modeling study from ChileCarlos Balmaceda, Manuel A Espinoza, Baltica Cabieses, et al.Pharmacoeconomics - Open|July 5, 2021
A Model-Based Economic Evaluation of Cladribine Versus Alemtuzumab, Ocrelizumab and Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in ChileManuel Antonio Espinoza, Rubén Rojas, Alessandro Zaupa, et al.Expert Review of Pharmacoeconomics & Outcomes Research|February 17, 2022
Cost-effectiveness analysis: fluticasone furoate/umeclidinium/vilanterol for the treatment of moderate to severe chronic obstructive pulmonary disease from the perspective of the Chilean public health systemCarlos Balmaceda, Manuel A Espinoza, Tomas Abbott, et al.Diabetology & Metabolic Syndrome|October 27, 2022
Health and economic effects on patients with type 2 diabetes mellitus in the long run: predictions for the Chilean populationManuel Antonio Espinoza, Tomas Abbott, Alvaro Passi, et al.BMC Palliative Care|January 11, 2023
Estimation of the demand for palliative care in non-oncologic patients in ChileNicolás Armijo, Tomás Abbot, Manuel Espinoza, et al.Value in Health Regional Issues|March 8, 2023
Cost-Effectiveness of Mepolizumab Add-On in the Treatment of Severe Eosinophilic Asthma in ChileTomas Abbott, Carlos Balmaceda, Paula Zamorano, et al.Plos One|July 26, 2024
Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non-small cell lung cancer in the context of the Chilean health care systemNicolás Armijo, Constanza Salas, Nazareth Espinoza, et al.International Journal for Equity in Health|August 23, 2023
The socioeconomic distribution of life expectancy and healthy life expectancy in ChileManuel Antonio Espinoza, Rodrigo Severino, Carlos Balmaceda, et al.Revista Medica De Chile|June 26, 2023
[The expected cost of cancer in Chile]Manuel A Espinoza, Nicolás Armijo, Tomás Abbott, et al.Pageof 4